FDA.reportPublic FDA data

0.4 ML methylnaltrexone bromide 20 MG/ML Prefilled Syringe [Relistor]

RxCUI
1244064
RxNorm name
0.4 ML methylnaltrexone bromide 20 MG/ML Prefilled Syringe [Relistor]
Display name
0.4 ML methylnaltrexone bromide 20 MG/ML Prefilled Syringe [Relistor]
Full name
0.4 ML methylnaltrexone bromide 20 MG/ML Prefilled Syringe [Relistor]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RelistorMETHYLNALTREXONE BROMIDESalix Pharmaceuticals, Inc.c488fb7c-0a5b-487c-b452-996809d1cb992024-05-01Warnings, Adverse reactionsExact identifier
rxcui: 1244064

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c488fb7c-0a5b-487c-b452-996809d1cb990.4 ML methylnaltrexone bromide 20 MG/ML Prefilled Syringe [Relistor]SBD68These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR ® (methylnaltrexone bromide) tablets, for oral use RELISTOR ® (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 200820240501
c488fb7c-0a5b-487c-b452-996809d1cb990.4 ML Relistor 20 MG/ML Prefilled SyringeSY68These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR ® (methylnaltrexone bromide) tablets, for oral use RELISTOR ® (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 200820240501
c488fb7c-0a5b-487c-b452-996809d1cb99RELISTOR 8 MG in 0.4 ML Prefilled SyringePSN68These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR ® (methylnaltrexone bromide) tablets, for oral use RELISTOR ® (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 200820240501
c488fb7c-0a5b-487c-b452-996809d1cb99Relistor 8 MG per 0.4 ML Prefilled SyringeSY68These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR ® (methylnaltrexone bromide) tablets, for oral use RELISTOR ® (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 200820240501